High-Sensitivity C-Reactive Protein and Cardiovascular Disease Across Countries and Ethnicities
Open Access
- 1 January 2016
- journal article
- review article
- Published by Elsevier BV in Clinics
- Vol. 71 (4), 235-242
- https://doi.org/10.6061/clinics/2016(04)11
Abstract
Despite substantial differences in ethnicities, habits, cultures, the prevalence of traditional cardiovascular risk factors and affordable therapies, atherosclerosis remains the major cause of death in developing and developed countries.Keywords
This publication has 67 references indexed in Scilit:
- Elevated Circulating Adipocyte‐Fatty Acid Binding Protein Levels Predict Incident Cardiovascular Events in a Community‐Based Cohort: A 12‐Year Prospective StudyJournal of the American Heart Association, 2013
- Myocardial infarction accelerates atherosclerosisNature, 2012
- Association between fasting plasma glucose and high-sensitivity C-reactive protein: gender differences in a Japanese community-dwelling populationCardiovascular Diabetology, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Usefulness of C-Reactive Protein as a Marker for Prediction of Future Coronary Events in the Asian Indian Population: Indian Atherosclerosis Research StudyInternational Journal of Vascular Medicine, 2010
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2010
- Implications of Increased C-Reactive Protein for Cardiovascular Risk Stratification in Black and White Men and Women in the USClinical Chemistry, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinThe New England Journal of Medicine, 2008
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysisThe Lancet, 2008
- Inflammation in atherosclerosisNature, 2002